AFRM vs AVBP · P/E 590, rev $3.22B vs $1.39B cap
Affirm Holdings Inc (AFRM) versus ArriVent BioPharma, Inc. Common Stock (AVBP) — a side-by-side from cached financials, not a winner call.
Affirm Holdings Inc (AFRM) is a software - infrastructure company listed on US.
ArriVent BioPharma, Inc. Common Stock (AVBP) is a biotechnology company listed on US.
Latest reported AFRM revenue for 2025-06-30 was $3.22B. Net income was $52.2M. Revenue was up 38.8% from 2024-06-30 to 2025-06-30. AFRM currently screens at market cap $28.80B and trailing P/E 589.7.
AVBP does not have a complete income-statement cache yet.
AFRM currently screens at market cap $28.80B and trailing P/E 589.7. AVBP currently screens at market cap $1.39B.
Not investment advice. Open the AFRM and AVBP stock pages for the full models.
Not investment advice.